今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

贾玲成功减重100斤引热议 专家提醒：减肥要循序渐进 注重健康

[北京讯] 近日，演员贾玲在社交平台上发布消息，称自己为了拍摄电影，在一年多的时间里成功减重100斤，引发网友热议。不少网友表示十分励志，也想效仿贾玲进行减肥。

然而，对于贾玲这种快速减肥的方式，一些专家表示了担忧。他们认为，减肥速度过快，不仅容易导致身体营养不良、肌肉流失，还可能引发一系列健康问题。

中国营养学会理事、注册营养师王思懿表示，减肥是一个循序渐进的过程，一般来说，每月减重4-8斤较为合理。如果减肥速度过快，身体来不及适应，就容易出现头晕、乏力、低血糖等症状。此外，快速减肥还会导致肌肉流失，基础代谢下降，不利于长期维持体重。

王思懿建议，想要减肥的市民应选择科学健康的方式，在专业人士的指导下制定合理的饮食和运动计划。同时，还要注意监测自己的身体状况，如果出现不适，应及时停止减肥并咨询医生。

除了贾玲之外，近年来也有不少明星通过快速减肥的方式来塑造身材。然而，这种极端的减肥方式往往会对身体造成不可逆的伤害。

专家提醒，减肥不能一味追求速度，而应以健康为前提。只有科学、理性的减肥，才能达到理想的效果，并保持长久的健康状态。

以下是一些快速减肥可能带来的健康风险：

• 营养不良：快速减肥往往意味着摄入的营养不足，会导致身体缺乏必要的营养素，影响免疫力，增加患病风险。
• 肌肉流失：减肥过程中，如果只减少脂肪摄入而不进行力量训练，会导致肌肉流失，基础代谢下降，更容易反弹。
• 胆结石：快速减肥，特别是低胆固醇饮食，会导致胆汁中的胆固醇过饱和，容易形成胆结石。
• 胃肠道疾病：快速减肥可能会导致胃肠道功能紊乱，出现腹痛、腹泻等症状。
• 厌食症、暴食症等心理疾病：过度节食或过度运动可能会引发厌食症、暴食症等心理疾病。

因此，想要减肥的市民应选择科学健康的方式，在专业人士的指导下制定合理的饮食和运动计划，并注意监测自己的身体状况。